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Objective: This study was designed to evaluate, histomorphometrically, the association of platelet-rich plasma (PRP) and bioactive glass (BG) in the treatment of periodontal 
intrabony defects. Material and Methods: Nine mongrel dogs were included in the study. 
Three-wall intrabony defects were surgically created at the mesial and distal aspect of 
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after the surgeries. The histometric parameters evaluated were: length of sulcular and 
junctional epithelium, connective tissue adaptation, new cementum, new bone, defect 
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was observed in PRP+BG and BG (13.80±2.32 mm2 and 15.63±2.64 mm2, respectively) 
when compared to the other groups (8.19±1.46 mm2 and 8.81±1.47 mm2 for control and 
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parameters. Conclusions: Within the limits of this study, it may be concluded that PRP failed 
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INTRODUCTION 
The ultimate goal of periodontal therapy includes 
not only the arrest of progressive periodontal 
disease but also the restitution of those parts 
of the supporting apparatus which have been 
destroyed by disease. Regenerative procedures 
have been evaluated in several studies using 
grafting materials, root surface conditioning, guided 
tissue regeneration and application of growth 
factors3,5,6,9.
Different materials have been introduced for 
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allografts, and alloplasts. Among the various 
subgroups of alloplastic bone grafts, bioactive glass 
(BG) is a type of bioactive ceramic with the ability 
to improve bone formation that has been assessed 
in experimental models13,27.
Previous studies have shown that BG 
particles, when implanted in vivo, incorporate 
into the connective tissue and undergo chemical 
transformation increasing the pH of the site to 
approximately 107,8. This process leads to the 
formation of a silica gel on the surface of the 
particles and subsequently an amorphous calcium 
phosphate layer is formed by the interaction 
between calcium and phosphate from the BG and 
the surrounding medium7. Hench and Polak8 (2002) 
have shown that the release of ions (Na, Ca, and 
Si) from BG materials controls the cell cycle leading 
to the differentiation and proliferation of bone cells, 
modulating the expression of genes that regulate 
osteogenesis, and the synthesis of growth factors.
Growth factors are vital modulators during 
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this process which can induce the migration, 
attachment, proliferation and differentiation of 
periodontal progenitor cells. Platelet-rich plasma 
(PRP) is a preparation of autologous plasma that 
contains a higher platelet concentration, allowing 
it to deliver a greater concentration of autologous 
growth factors such us platelet-derived growth 
factor (PDGF), transforming growth factor beta 
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insulin-like growth factor (IGF-I), and epithelial 
growth factor (EGF), that regulate cell proliferation, 
chemotaxis and differentiation17.
Some specific platelet growth factors, like 
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differentiation of the periodontal ligament and 
alveolar bone cells and could be responsible for 
the clinical improvement observed in experimental 
sites29. Other interesting feature of PRP is its sticky 
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component of PRP may work as a haemostatic agent 
aiding in stabilizing the graft material and the blood 
clot22. Blood clot immobilization has been suggested 
as an important event in the early phases of wound 
healing of periodontal regenerative procedures22.
Studies using histological techniques suggested 
that PRP preparations may enhance local bone 
formation17, while others10 
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findings. Clinical studies have reported that 
treatments with a combination of PRP and 
demineralized freeze-dried bone graft allograft 
(DFDBA) improve clinical parameters in intrabony 
periodontal defects21. In the other hand4
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with BG in the treatment of intrabony defects.
The use of PRP associated with biomaterials is an 
alternative treatment approach that may favor the 
process of bone tissue regeneration and should be 
investigated. Therefore, the goal of this study was 
to evaluate, histomorphometrically, the healing of 
surgically created intrabony defects in dogs treated 
with PRP+BG.
MATERIAL AND METHODS
Nine adult female mongrel dogs (mean weight=15 
kg) were included in the experiment. The study 
protocol was approved by the Institutional Animal 
Research Committee, State University of Campinas 
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were performed under general anesthesia with 
intravenous injection of a 3% sodium pentobarbital 
solution (0.5 mL/kg). The mandibular second and 
fourth premolars had been previously extracted 
and the extraction sites had been allowed to heal 
for 2 months. After this period, buccal and lingual 
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intrabony defects (4x4x4 mm) were created at 
the mesial and distal aspect of the left and right 
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;14. Following root 
planning, aiming cementum removal, a reference 
notch was made with curettes on the root surface 
at the cement-enamel junction.
Before that the gingival flaps have been 
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by cotton ligature was adapted over the tooth 
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gutta-percha (Figure 2). So, the defects were 
exposed to plaque accumulation for a period of 
one month before the treatment. After that, scaling 
and root planing was performed and a regimen 
of daily brushing plus topical application of 0.1% 
chlorhexidine gluconate was instituted for 7 days 
prior to the surgical procedures.
Figure 1- Clinical view of the surgically created 3-wall 
intrabony defect (4x4x4 mm) at the mesial aspect of the 
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Figure 2- Clinical view of the insertion of gutta-percha in 
the defect
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PRP Preparation
Blood was obtained several min before the 
administration of anesthesia. Four 5-mL tubes 
containing 0.5 mL of 3.2% sodium citrate solution 
(an anticoagulant) were drawn from each dog. 
Three tubes were centrifuged at 1,200 rpm for 
10 min at room temperature. The blood was thus 
separated into 3 basic parts: red blood cells (at 
the bottom of the tube), platelet enriched plasma 
(a discrete grey line in the middle of the tube) and 
platelet poor plasma (at the top of the tube). The 
portion corresponding to the platelet poor plasma 
was discarded from each tube and the remaining 
content was centrifuged again at 1,200 rpm for 15 
min. Four hundred microliters of the middle portion, 
corresponding to the platelet enriched plasma, were 
pipetted from each tube. In order to obtain the gel, 
30 μL of 10% calcium chloride was added to PRP 
and heated in a water bath at 37°C. The gel was 
achieved after a period of 10 to 15 min2,26. A tube 
with a sample of whole blood as well as a sample 
of PRP, retrieved before adding calcium chloride of 
10%, was sent to a clinical veterinary laboratory 
to perform a platelet counting.
Defect Treatment
In the moment of the defect treatment, an 
apical reference notch was made with curettes 
on the root surface at the remaining bone level. 
Each defect in each animal (a total of 4 defects/
animal) was randomly assigned to one of the 
following treatments (the treatments with PRP 
were located at the same side that was randomly 
determined): Control
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

with coagulum; BG (Perioglas, US Biomaterials, 
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the defect; PRP: after obtaining the PRP gel, it 
was immediately applied on the defect; PRP+BG: 
BG was incorporated to the PRP (1:1) and this 
assemblage was immediately taken to a water bath 
at 37ºC for formation of a mixture of the gel and 
the BG graft.
Primary, tension-free wound closure was 
accomplished following defect treatment, with 
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interrupted sutures (Vicryl, Ethicon INC, São José 
dos Campos, SP, Brazil) at their presurgical position. 
Immediately after the surgeries, an intramuscular 
injection of penicillin (1.5 mL – 150,000 IU) was 
given to the animal.
Postoperative plaque control was performed 
by irrigation with a solution of 1% chlorhexidine 
gluconate (every other day). After 90 days, under 
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with a perfusion of 10% neutral formalin solution. 
The jaws were dissected and the blocks containing 
the experimental specimens were removed, and 
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formic acid and 20% sodium citrate for 5 months. 
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water, dehydrated and embedded in paraffin. 
Mesiodistal 7-m-thick sections were obtained and 
stained with hematoxylin and eosin.
Five sections representing the midbuccal portion 
of each defect were selected for the histometric 
procedures. The sections were analyzed by one 
masked examiner. The following distances were 
measured:
Total epithelium (sulcular and junctional 
epithelium): from the gingival margin to the apical 
border of the junctional epithelium.
Connective t issue adaptation (without 
cementum): from the apical border of the junctional 
epithelium to the coronal end of new cementum.
New cementum: from the apical notch to the 
most coronal part of new cementum.
New bone (bone position): from the apical notch 
to the most coronal extent of new bone. Negative 
values would be assigned if the bony crest was 
located apically to the apical notch.
New bone area: 	
		
the defect area (limited by the distance between the 
two notches in an apico-coronal direction and 4 mm 
away from the root surface in a lateral direction). 
The area of new bone was measured with an image 
analysis system that allowed the placement of a 
lattice on the image of the created bone defect. The 
intersection lines localized on bone were marked to 
calculate the new bone area whereas intersections 
lines localized on BG particles were not marked 
and therefore were not included for this purpose.
Defect extension: from the apical notch to the 
coronal notch.
The measurements were performed using 
a microscope (Zeiss Axioskop 2, Carl Zeiss 
Instruments, Gottingen, Lower Saxony, Germany) 
with a 1.25/.035 objective associated with a video 
camera/computer/software (Image Pro Plus Version 
3.0, Media Cybernetics, Silver Spring, MD, USA).
Statistical analysis
Mean values for each parameter were obtained 
per defect. The mean values for all groups were 
determined using the individual means from the 9 
dogs. The hypothesis that there were no differences 
among the groups was tested by one-way ANOVA. 
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Tukey’s pairwise multiple comparison test was used.
RESULTS
I - Clinical Observations 
Clinically, the healing response was favorable for 
all treatments. No suppuration or abscess formation 
was observed during the 90 days.
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II - Histological Observations
No undesirable events like 	^	 	

foreign body reactions were observed. All groups 
presented a similar healing pattern characterized 
mainly by the presence of new cementum covering 
most of the root surface associated with the 
defect and new bone, up to the top of the defect, 
with a small amount of connective tissue and 
epithelium (Figure 3). The periodontal ligament 
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obliquely oriented to the root surface, extending 
between the new cementum and the newly formed 
bone.
In the defects treated with BG, it was possible 
to observe that part of the material seemed to 
be resorbed and replaced by bone, while some of 
the remaining BG particles showed dissolution of 
their central part with newly formed bone inside 
of them. Some defects presented bone in direct 
contact and/or surrounding the BG particles (Figure 
4). Almost all defects that received BG presented a 
dense connective tissue surrounding the remaining 
particles and areas suggesting the formation of 
new bone. Root resorption and ankylosis were not 
observed.
III – Histometric Measurements
The histometric results are shown in Table 1. 
A superior area of new bone was observed in the 
sites treated with PRP+BG and BG (13.80±2.32 
mm2 and 15.63±2.64 mm2, respectively). In the 
other groups, the new bone area was 8.19±1.46 
mm2 (control group) and 8.81±1.47 mm2 (PRP). 
Although the difference in the new bone area, 
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parameter new bone, e.g. bone position: from the 
apical notch to the most coronal extent of new bone 
(4.37±0.44 mm, 4.24±0.68 mm, 4.37±0.46 mm 
and 4.44±0.42 mm, for control group, BG, PRP and 
PRP+BG, respectively; p=0.85).
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among the groups regarding the initial defect 
extension (4.55±0.17 mm, 4.48±0.20 mm, 
4.48±0.28 mm and 4.57±0.32 mm, for control 
group, BG, PRP and PRP+BG, respectively; p=0.74). 
In addition, intergroup analysis demonstrated that 
no significant difference was observed among 
the groups in the following parameters: total 
epithelium extension (2.24±0.58 mm, 1.94±0.37 
mm, 1.97±0.37 mm and 1.81±0.61, for control 
group, BG, PRP and PRP+BG, respectively; p=0.45), 
connective tissue extension (0.90±0.28 mm, 
0.84±0.41 mm, 1.07±0.27 mm and 1.15±0.32 
mm, for control group, BG, PRP and PRP+BG, 
respectively; p=0.59) and new cementum extension 
(2.63±0.70 mm, 2.56±0.36 mm, 2.37±0.38 mm 
and 3.10±0.47 mm, for control group, BG, PRP and 
PRP+BG, respectively; p=0.85).
The results from the histometric measurements, 
i.e., epithelial length (the portion of epithelium 
located on the root), connective tissue adaptation 
and new cementum formation, expressed as the 
Figure 3- Photomicrographs of the treated 3-wall intrabony 
defect showing new bone and cementum formation 
extending coronally to the apical notch (H&E, original 
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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Note the remaining particles of BG surrounded by new bone 
and connective tissue (C and D). Arrows indicate areas 
with new bone in contact with BG particles
Figure 4- New bone formation observed in the 3-wall 
		!
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x100). Arrows indicate bone in direct contact with BG 
particles
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percentage of the distance between the coronal and 
the apical notch are presented in Figure 5.
DISCUSSION
The use of different regenerative approaches 
in the treatment of periodontal defects has 
demonstrated a variable clinical result3,6,9. Some 
techniques have been used in association, aiming to 
increase their effect on periodontal regeneration5,17. 
The present study was designed to evaluate, 
histomorphometrically, the healing process of 3-wall 
intrabony defects treated with BG, PRP and their 
association.
PRP has become a focus of current studies due to 
its potential to accelerate wound healing11,12. It has 
been previously shown that PRP stimulated PDL cells 
	
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	11,12 but suppressed 
epithelial cell division in vitro19. Consequently, by 
ordering these cellular responses into a series of 
related events, PRP may facilitate wound-healing and 
tissue regeneration. The claimed ability to suppress 
epithelial cell proliferation seems advantageous for 
periodontal regeneration by favoring the formation 
of a new connective tissue attachment and new 
cementum on the root surface26. The results of the 
present study failed to demonstrate that the use 
of PRP can promote an additional effect in terms of 
cementum formation when treating 3-wall intrabony 
defects. Cementum formation for BG and PRP 
followed the same trend observed for the control 
group (BG=2.5 mm/57%, PRP=2.4 mm/53%, 
control=58%) while the PRP+BG showed a slightly 
greater cementum formation (PRP+BG=3.10 
mm/68%), but the differences among the groups 
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should be recognized that a non-contained osseous 
defect might have favored the discrimination of 
quantitative differences among the treatments.
In a previous histological study, Kim, et al14 
(2004) evaluated the healing patterns following 
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3-wall intrabony defects. According to the authors, 
one- and 3-wall intrabony defects can be considered 
pre-clinical models that are relatively easy to 
manage and from which homogeneous healing 
outcomes may be expected. They suggested that 
these defects appear to be reproducible models 
to evaluate candidate technologies for periodontal 
regeneration14. Regarding the 3-wall intrabony 
defect, they reported a mean cementum formation 
of approximately 70% of the initial defect extension. 
In the present study, a period of 1 month of plaque 
accumulation was allowed as a way to obtain some 
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showed 2.6 mm (58%) of the original defect 
/
			
the high regenerative potential of this type of defect 
that provides favorable anatomic characteristics for 
clot stabilization and protection.
It is well accepted that healing of intrabony 
defects is positively correlated to the number of 
bone walls limiting the defect. Therefore, the 3-wall 
intrabony defect used in the present study provides 
ideal extent and location of tissue resources, cells 
and vascularity circumscribing the defect, which 
might have favored bone formation. The linear 
measurement of the new bone height revealed 
an impressive coronal bone formation for all the 
			
		
treatments.
Figure 5- Histometric parameters expressed as a 
percentage of the defect
              Mean ± SD 
Parameters
Control BG PRP BG+PRP p†
Total epithelium 2.24±0.58a 1.94±0.37a 1.97±0.37a 1.81±0.61a 0.45
Connective tissue 0.90±0.28a 0.84±0.41a 1.07±0.27a 1.15±0.32a 0.59
New cementum 2.63±0.70a 2.56±0.36a 2.37±0.38a 3.10±0.47a 0.85
New bone 4.37±0.44a 4.24±0.68a 4.37±0.46a 4.44±0.42a 0.85
New bone area 8.19±1.46a 15.63±2.64b 8.81±1.47a 13.80±2.32b <0.0001
Defect extension 4.55±0.17a 4.48±0.20a 4.48±0.28a 4.57±0.32a 0.74
Table 1- Mean and Standard Deviation (SD) for the parameters evaluated after all the treatments (Control, BG, PRP and 
BG+PRP). Means followed by different letters are statistically different at 5%
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The claimed osteoinductive properties of PRP18 
could not be supported by the results of the present 
study. It has been suggested that PRP could be used 
to increase the bone deposition rate and the quality 
of bone regeneration when augmenting sites prior 
to or in conjunction with dental implant placement. 
Nevertheless, more recent animal studies could not 
	
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used10,13,18.
Recently, bioactive glass has been used as a way 
to achieve bone and periodontal regeneration based 
on its osteoconductive properties3,4,18,27. The need 
for an alternative to autologous and allogenic bone 
grafts have encouraged the search of a material that 
could be safe, surgically convenient and predictably 
promote regeneration with a reduced morbidity. In 
this study, the use of BG was not associated with 
any foreign body reaction, showing biocompatibility 
with periodontal tissues. Healing events such as 
ankylosis and root resorption were not observed. 
This observation is in agreement with previous 
studies using BG in animals7.
Histological observations after treatment of 
periodontal defects with BG in nonhuman primates 
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inhibition of downgrowth of junctional epithelium27. 
When BG is implanted in vivo, the pH of the site 
increases, a layer rich in silica gel is formed on 
the surface of the particles and subsequently an 
amorphous calcium phosphate layer is formed by 
the interaction between calcium and phosphate from 
the BG and the surrounding medium7
bioactivity may stimulate a rapid formation of a 
connective tissue seal that is supposed to have the 
ability to block the epithelium migration and allow 
for the repopulation of the previously contaminated 
area by periodontal ligament cells7. In the present 
study, almost all defects that received BG presented 
a dense connective tissue surrounding the 
remaining particles in accordance with observations 
of previous studies27.
In the groups treated with BG, the area of 
new bone was 13.80±2.32 mm2 (PRP+BG) and 
15.63±2.64 mm2 (BG), respectively. In the groups 
that did not receive this material, the new bone area 
was 8.19±1.46 mm2 (control group) and 8.81±1.47 
mm2 ="#"; 
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observed in the area of newly formed bone when 
groups with and without BG were compared the 
present study corroborates the hypothesis that 
this material could act as an osteoconductive graft. 
In addition, it was observed that some remaining 
BG granules showed dissolution of their core with 
newly formed bone, as described in the literature28.
Aiming to increase the periodontal and bone 
regeneration, some studies evaluated the additional 
effect of PRP, combined with different types of 
grafting materials, on the treatment of intrabony 
defects. In spite of some clinical results showing 
a greater reduction of pocket depth and gain in 
clinical attachment level, other clinical studies failed 
to demonstrate an additional effect. In 3-wall peri-
implant defects in dogs treated with PRP associated 
to xenogenic bone graft, PRP demonstrated a low 
bone regenerative potential25. The same authors 
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of PRP to xenogenic bone grafts on bone mineral 
density or graft maturity24. These observations are 
in agreement with the results of the present study, 
which could not demonstrate an additional effect of 
PRP in periodontal and bone regeneration of 3 wall 
		
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	
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demonstrated that the sites treated with PRP+BG 
showed a similar amount of new bone (13.80±2.32 
mm2) when compared with the sites that only 
received BG (15.63±2.64 mm2).
The ideal platelet and growth factor concentration 
to promote periodontal regeneration has not yet 
	
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information about growth factor interactions and how 
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and protein production. In the present study, the 
achieved percentage mean of platelet concentration 
was 227.02% (mean of 463.015 platelets/mL) in 
relation to blood platelets count. Lacoste, et al.15 
(2003) reported that growth factors may act at 
  	
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and this may be other explanation for the different 
results obtained in studies evaluating the use of PRP. 
The great variability in the outcomes of the studies 
with PRP may also be explained by the diversity 
of methods to obtain it. The technique to produce 
PRP in the present study was used in other animal 
studies by our research group2,26. This technique 
enables the production of a platelet concentration 
generally four times greater than the whole blood. 
According to Landsberg, et al.16 (1998), thrombin 
promotes the release of antibodies to coagulation 
factors V and VI, which could be a potentially life-
threatening event. These antibodies cross-react 
with human factor V thereby, causing a factor V 
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excessive bleeding and even death. Considering 
that, the use of thrombin in this type of study is not 
allowed in our country. In the present study, instead 
of thrombin, 10% calcium chloride was added to 
PRP and heated in a water bath at 37°C. Lacoste, 
et al.15 (2003) measured the concentrations of 
>!>EI!>"%!>?	
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platelet concentrate and whole blood, before and 
after the addition of calcium alone, thrombin alone 
and various concentrations of calcium and thrombin. 
Those authors observed that calcium chloride, 
regardless of the use of thrombin, released platelet 
growth factors. In this study15, the concentration 
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to promote endothelial cell proliferation in vitro.
Recently, the tissue engineering science has 
provided a new possibility of cell therapy as a 
future alternative for the use of conventional 
regenerative techniques1. This strategy that exploits 
the regenerative capacity of stem cells grown in 
a three-dimensional scaffold and subsequently 
implanted into the defect, in the presence of 
molecule modulators, may help overcoming several 
limitations of current regeneration modalities1. In 
an in vitro study, the application of growth factors 
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periodontal ligament cells, increased their mitotic 
activity and their capacity for adhesion on the root 
fragments surface20,23. The use of platelet growth 
factors associated with cell therapy could be an 
alternative favoring the process of periodontal 
regeneration.
CONCLUSIONS
Within the limits of this animal model study, it 
may be concluded that the association of PRP with 
BG did not exert an additional effect to periodontal 
regeneration of 3-wall intrabony defects in dogs. 
Further studies are necessary to investigate the 
advantages and limitations of these materials in 
the treatment of periodontal defects. 
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